Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Crosses Above 50 Day Moving Average – Here’s Why

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s stock price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $266.71 and traded as high as $321.12. Bio-Rad Laboratories shares last traded at $321.12, with a volume of 218 shares traded.

Bio-Rad Laboratories Stock Performance

The firm’s fifty day moving average price is $266.71 and its 200-day moving average price is $252.53. The company has a current ratio of 5.12, a quick ratio of 3.67 and a debt-to-equity ratio of 0.17. The company has a market cap of $8.74 billion, a P/E ratio of 27.38 and a beta of 0.81.

Bio-Rad Laboratories (NYSE:BIO.B) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.61 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a net margin of 12.50% and a return on equity of 4.01%. The company had revenue of $651.60 million for the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.